. 2004; 15(3): 137-139 | |||
Yüksek Psa Değeri Büyük Hacimli Ve Semptomatik Prostat Hiperplazili Hastalarin Cerrahi Tedavisine Engel Mi? Olgunun Retrospektif İncelenmesiCemal Göktaş, Önder Cangüven, Mustafa Bülbül, Erkan Hirik, Selami AlbayrakDr. Lütfi Kırdar Kartal Eğitim Ve Araştırma Hastanesi 2. Üroloji KliniğiAMAÇ: Does The High Psa Value Pose An Obstacle For The Surgical Treatment Of Patients With High Volume And Symptomatic Prostate Hyperplasia? Retrospective Analysis Of 231 CasesCemal Göktaş, Önder Cangüven, Mustafa Bülbül, Erkan Hirik, Selami AlbayrakDr. Lütfi Kırdar Kartal Eğitim Ve Araştırma Hastanesi 2. Üroloji KliniğiOBJECTIVE: In this study, to evaluate the postoperative pathological results, in terms of incidental prostate cancer (IPCa), of the benign prostate hyperplasia (BPH) patients, especially having prostate specific antigen (PSA) value in excess of 4 ng/ml, high prostate volume, negative biopsy results and on whom we had performed surgical treatments, was aimed. We evaluated 231 patients retrospectively. All patients’ rectal examination, total and free PSA values, prostate volumes, if performed the transrectal ultrasound biopsy and postoperative pathologic results were recorded. Patients were divided into two groups, having PSA level below and above 4 ng/ml and their results were compared in terms of malignity. In 7 (3%) cases, the prostate adenocancer was reported in the postoperative pathologic results. All of the cases with cancer diagnosis were in group 2 (p<0.05). Total PSA was 1.8 (0.7-3.9) ng/ml in the first group and 6.2 (4-13.5) ng/ml in the second group. Cancer detected 7 patients’ PSA average was 8.4 (6.2-13.2) ng/ml (p<0.05). Prostate volume was 53 cc in cancer-detected patients (p<0.05). Incidental cancer rate was 8% (7/87) in second group patients. Patients with BPH whose PSA level is in gray zone should be evaluated for cancer. We found that incidental cancer was less in these patients who have high prostate volume. Risk of cancer shouldn’t be seen as an obstacle for their treatment. However we should remember in mind that although risk of incidental cancer decrease, it can be seen always. Cemal Göktaş, Önder Cangüven, Mustafa Bülbül, Erkan Hirik, Selami Albayrak. Does The High Psa Value Pose An Obstacle For The Surgical Treatment Of Patients With High Volume And Symptomatic Prostate Hyperplasia? Retrospective Analysis Of 231 Cases. . 2004; 15(3): 137-139 Sorumlu Yazar: Cemal Göktaş |
|